Column Group Ii, Lp - Net Worth and Insider Trading
Column Group Ii, Lp Net Worth
The estimated net worth of Column Group Ii, Lp is at least $6 Million dollars as of 2024-12-01. Column Group Ii, Lp is the 10% Owner of RAPT Therapeutics Inc and owns about 4,425,439 shares of RAPT Therapeutics Inc (RAPT) stock worth over $6 Million. Details can be seen in Column Group Ii, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Column Group Ii, Lp has not made any transactions after 2022-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Column Group Ii, Lp
Column Group Ii, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Column Group Ii, Lp owns 8 companies in total, including RAPT Therapeutics Inc (RAPT) , NGM Biopharmaceuticals Inc (NGM) , and Nurix Therapeutics Inc (NRIX) among others .
Click here to see the complete history of Column Group Ii, Lp’s form 4 insider trades.
Insider Ownership Summary of Column Group Ii, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RAPT | RAPT Therapeutics Inc | 2022-05-25 | 10 percent owner |
| NGM | NGM Biopharmaceuticals Inc | 2019-04-03 | 10 percent owner |
| NRIX | Nurix Therapeutics Inc | 2021-05-07 | 10 percent owner |
 | | 2021-11-12 | 10 percent owner |
| | 2019-04-02 | 10 percent owner |
| | 2018-09-27 | 10 percent owner |
| | 2018-03-14 | 10 percent owner |
| | 2021-08-25 | 10 percent owner |
Column Group Ii, Lp Latest Holdings Summary
Column Group Ii, Lp currently owns a total of 1 stock. Column Group Ii, Lp owns 4,425,439 shares of RAPT Therapeutics Inc (RAPT) as of May 25, 2022, with a value of $6 Million.
Latest Holdings of Column Group Ii, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics Inc | 2022-05-25 | 4,425,439 | 1.26 | 5,576,053 |
Holding Weightings of Column Group Ii, Lp
Column Group Ii, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Column Group Ii, Lp has made a total of 13 transactions in RAPT Therapeutics Inc (RAPT) over the past 5 years, including 6 buys and 7 sells. The most-recent trade in RAPT Therapeutics Inc is the acquisition of 1,900 shares on May 25, 2022, which cost Column Group Ii, Lp around $23,655.
Insider Trading History of Column Group Ii, Lp
- 1
Column Group Ii, Lp Trading Performance
GuruFocus tracks the stock performance after each of Column Group Ii, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Column Group Ii, Lp is 141.07%. GuruFocus also compares Column Group Ii, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Column Group Ii, Lp within 3 months outperforms 7 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Column Group Ii, Lp's insider trading performs compared to the benchmark.
Performance of Column Group Ii, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 56.05 | | | | | |
| Relative Return to S&P 500(%) | 57.3 | | | | | |
Column Group Ii, Lp Ownership Network
Column Group Ii, Lp Owned Company Details
What does RAPT Therapeutics Inc do?
Who are the key executives at RAPT Therapeutics Inc?
Column Group Ii, Lp is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Tcg Iv Gp, Llc .
RAPT Therapeutics Inc (RAPT) Insider Trades Summary
Over the past 18 months, Column Group Ii, Lp made no insider transaction in RAPT Therapeutics Inc (RAPT). Other recent insider transactions involving RAPT Therapeutics Inc (RAPT) include a net sale of 9,000 shares made by William Ho , and a net sale of 898 shares made by Dirk G. Brockstedt .
In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc (RAPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,898 shares of RAPT Therapeutics Inc (RAPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,898 shares.
RAPT Therapeutics Inc (RAPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
RAPT Therapeutics Inc Insider Transactions
Column Group Ii, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Column Group Ii, Lp. You might contact Column Group Ii, Lp via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
